Adverse events of rituximab in neuromyelitis optica spectrum disorder: a systematic review and meta-analysis

Adverse events of rituximab in neuromyelitis optica spectrum disorder: a systematic review and meta-analysis

Background: The adverse events (AEs) of rituximab (RTX) for neuromyelitis optica spectrum disorder (NMOSD) are incompletely understood. Aim: To collate information on the reported the AEs of RTX in NMOSD and assess the quality of evidence. Methods: PubMed, EMBASE, Web of Science, Cochrane Library, W...

Full description

Bibliographic Details
Main Authors: Hao Wang, Juanping Zhou, Yi Li, Lili Wei, Xintong Xu, Jianping Zhang, Kehu Yang, Shihui Wei, Wenfang Zhang
Format: Article
Language:English
Published: SAGE Publishing 2021-12-01
Series:Therapeutic Advances in Neurological Disorders
Online Access:https://doi.org/10.1177/17562864211056710

Internet

https://doi.org/10.1177/17562864211056710

Similar Items